ArticleEuropean urology2025

Re: Bladder-preserving Trimodality Treatment for High-grade T1 Bladder Cancer: Results from Phase II Protocol NRG Oncology/RTOG 0926.

Melinda Z Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.